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Organochlorines (OCs) constitute a family of
persistent, lipid-soluble compounds that
includes industrial chemicals [e.g., polychlori-
nated biphenyls (PCBs), hexachlorobenzene
(HCB)], pesticides (e.g., DDT, methoxychlor,
mirex), and by-products of combustion and
various industrial processes [e.g., poly-
chlorodibenzo-p-dioxins (PCDDs) and poly-
chlorodibenzofurans (PCDFs)]. These
compounds are released into the environment
at southern latitudes and transported to
northern regions by long-range oceanic and
atmospheric transport processes (Barrie et al.
1992; Macdonald et al. 2000). OCs bio-
accumulate in adipose tissues of various
species from northern aquatic ecosystems.
Biomagniﬁcation occurs in food webs, leading
to relatively elevated concentrations in species
located at the highest trophic levels, including
human populations that consume large
amounts of sea products (Dewailly et al. 1993;
Kiviranta et al. 2002; Sjödin et al. 2000).
The Lower North Shore of the St. Lawrence
River, a remote coastal region of Québec, con-
sists of 15 communities spread over a 400-km
shoreline extending from Kegaska to Blanc
Sablon (Figure 1). A large proportion of the
6,000 residents relies on ﬁshing for subsistence
and consequently consumes large amounts of
seafood (Dewailly et al. 1992). Results from
surveys conducted since 1990 have indicated
that this population is highly exposed to PCBs
and to dioxin-like compounds (DLCs) such
as 2,3,7,8-substituted PCDDs and PCDFs
as well as nonsubstituted and mono-ortho–
substituted PCBs, compared to the southern
Québec population (Dewailly et al. 1992;
Muckle et al. 1998; Ryan et al. 1997). Food
items that contribute the most to this exposure
are sea-bird eggs and possibly cod and seal liver
(Dewailly et al. 1992; Ryan et al. 1997).
Exposure to DLCs produces a wide variety
of biologic and toxic effects such as terato-
genesis, immunosuppression, and tumor pro-
motion, most of them dependent on the
activation of the aryl hydrocarbon receptor
(AhR) (Mimura and Fujii-Kuriyama 2003;
Poland and Knutson 1982; Safe 1990; Van
den Berg et al. 1998). We previously reported
on a group of 25 individuals from the Lower
North Shore of the St. Lawrence River that
had a mean total DLC concentration of
250 ng of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) toxic equivalents (TEQ)/kg plasma
lipids, including PCDDs, PCDFs, and non-
substituted and mono-ortho PCBs (Ryan et al.
1997). Assuming a 20% body fat content in
humans, the corresponding body burden
would be 50 ng TEQ/kg body weight. In
laboratory animals exposed to TCDD, adverse
effects (hormonal, reproductive, and develop-
mental) have been observed at body burdens in
the range of 28–73 ng TCDD/kg body weight
(van Leeuwen et al. 2000), hence suggesting
that DLC exposure in this ﬁsh-eating popula-
tion might induce adverse health effects.
To reﬁne the assessment of the health risks
possibly related to the body burden of DLCs
and other OCs in this ﬁsh-eating population,
investigators can measure early biologic events
such as the induction of drug-metabolizing
enzyme activities. Activation of genes coding
for biotransformation enzymes such as cyto-
chrome P4501A1 (CYP1A1) and CYP1A2 is a
well-known consequence of TCDD binding
to the AhR (Walker et al. 1999; Whitlock
1999). Liver CYP1A2 activity in humans can
be measured in vivo by a noninvasive method,
the caffeine breath test (CBT; Kotake et al.
1982). In this test, CYP1A2 activity is moni-
tored by following the appearance of 13CO2 in
exhaled breath resulting from the oxidative
demethylation of [3-13C-methyl]caffeine
(Abraham et al. 2002; Brambilla et al. 1995;
Kotake et al. 1982; Lambert et al. 1990). The
concentration of D-glucaric acid in urine has
also been proposed as a biomarker of exposure
to xenobiotics (Brewster 1988; Hogue and
Brewster 1991; Poon et al. 1993). Glucuroni-
dation is a major biotransformation pathway
for a wide variety of xenobiotics and drugs,
and its induction results in increased excre-
tion of D-glucaric acid (Brewster 1988).
Urinary D-glucaric acid excretion has also
been shown to increase in humans exposed to
OC pesticides (Hunter et al. 1972; Notten and
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The Lower North Shore region of the St. Lawrence River is home to a ﬁsh-eating population that
displays an unusually high body burden of several organochlorines, including polychlorinated
biphenyls (PCBs) and dioxin-like compounds (DLCs). We measured biomarkers indicative of liver
enzyme induction and investigated the relationship with organochlorine body burden in adult volun-
teers from this population. We determined plasma concentrations of PCBs and chlorinated pesti-
cides by high-resolution gas chromatography (HRGC) with electron capture detection. DLC
concentrations were measured by the dioxin-receptor chemically activated luciferase expression
(DR-CALUX) assay and in a subset of participants, by HRGC/high-resolution mass spectrometry.
We measured cotinine, D-glucaric acid, and porphyrins in morning urine samples and determined
liver CYP1A2 activity in vivo using the caffeine breath test. Neither DLC concentrations as meas-
ured by the DR-CALUX nor PCB-153 concentrations, the latter representing total PCB exposure,
were correlated with biomarkers of effects. Smoking (morning urinary cotinine concentration) was
positively related to CYP1A2 activity as measured by the caffeine breath test (p < 0.01). Liver
CYP1A2 activity was in turn negatively correlated with PCB-105:PCB-153 and PCB-118:PCB-153
congener ratios (p < 0.05). Hence, despite the relatively high body burden of PCBs and DLCs in this
population, only smoking had a signiﬁcant correlation with biomarkers of hepatic enzyme induction.
Our data are consistent with smoking-induced liver CYP1A2 activity altering heme metabolism and
increasing the biotransformation of mono-ortho PCB congeners. Key words: cytochrome P450
CYP1A2, D-glucaric acid, dioxins, enzyme induction, food chain, organochlorine insecticides, poly-
chlorinated biphenyls, porphyrins, smoking. Environ Health Perspect 113:1318–1324 (2005).
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and TCDD (Ideo et al. 1982). Urinary por-
phyrin excretion can also be altered by exposure
to xenobiotics such has PCBs (Colombi et al.
1982), polybrominated biphenyls (Strik et al.
1979), and TCDD (Hoffman et al. 1986; Jung
et al. 1994). Provided sufﬁcient exposure dose,
all these chemicals induce chronic disturbances
in hepatic synthesis of porphyrins and thus lead
to excess total porphyrin excretion and skin
symptoms in the final stage (Hogue and
Brewster 1991). Presumably, these chemicals
would also alter urinary porphyrin profile at
early stages before overt toxicity, and therefore,
the latter constitutes a much more sensitive bio-
marker than total porphyrin determination
(Johnson et al. 1988).
In the present study, we measured concen-
trations of porphyrins and D-glucaric acid in
urine samples and performed the CBT in vol-
unteers from two communities located on the
Lower North Shore of the St. Lawrence River.
We measured plasma lipid concentrations
of PCBs and chlorinated pesticides by high-
resolution gas chromatography (HRGC) with
electron capture detection (ECD) and DLCs
by the dioxin-receptor chemical-activated
luciferase gene expression (DR-CALUX) bio-
assay. Finally, because tobacco smoking can
induce liver enzyme activities, smoking status
was assessed by questionnaire and validated
using urinary cotinine measurements.
Materials and Methods
Study population and measurements. We
recruited participants in this study from two
Lower North Shore settlements: Tête-à-la-
Baleine and La Tabatière (Figure 1). Potential
subjects were selected from the list of those who
participated in a previous survey (Dewailly et al.
1992), and therefore, their concentration of
OCs in plasma lipids was already known. We
tried to recruit individuals with both high and
low exposure to PCBs. Our research nurse
contacted potential subjects by telephone and
asked interested individuals to visit their local
health center the week after for an information
meeting. After a brief medical examination,
subjects with cardiac arrhythmia, uncontrolled
hypertension, or with a history of caffeine
intolerance were excluded from the study. An
80-mL venous blood sample was drawn from a
cubital vein and collected in Vacutainer
(Becton Dickinson, Franklin Lakes, NJ, USA)
tubes (10 mL) containing EDTA as the anti-
coagulant. Tubes were centrifuged (10 min)
immediately after blood sampling, and plasma
samples were kept frozen (–15°C) in plain
Venoject tubes (10 mL) until OC analysis at
the Laboratoire de Toxicologie (Institut
National de Santé Publique du Québec,
Québec, QC, Canada). Volunteers were also
asked to collect their first urine on the next
morning in a plastic vial containing sodium
bicarbonate (0.5 g/10 mL urine). Urine sam-
ples were kept frozen (–15°C) until analysis for
D-glucaric acid and cotinine (Environmental
Health Science Bureau, Health Canada,
Ottawa, Ontario, Canada) and porphyrins and
creatinine (Division of Biochemistry, Ottawa
Hospital, Ottawa, ON, Canada). Finally,
volunteers were asked to fast for 6 hr and not
to drink or eat methylxanthine-containing
foods (chocolate, coffee, tea, cola) for 12 hr
before the CBT, which was conducted the
next morning.
We obtained anthropometric measure-
ments (weight, height), and administered a
short questionnaire to obtain information on
current medication and smoking and drinking
habits. We obtained informed consent from
participants before administering the ques-
tionnaire and collecting biologic samples. This
study was approved by the Ethics Committee
from Laval University Medical Center (Centre
Hospitalier Universitaire de Québec).
Caffeine breath test. The CBT was admin-
istered as previously described by Kotake et al.
(1982). Briefly, [3-13C-methyl]caffeine
(Cambridge Isotopes, Cambridge, MA, USA)
dissolved in water (10 mg/mL) was adminis-
tered orally at a dose of 3 mg/kg body weight
(up to a maximum of 200 mg). Subjects were
asked to remain seated for 15 min before the
test and during the 2-hr period after caffeine
administration. Before drinking the caffeine
solution, volunteers exhaled into an air collec-
tion device made of a modiﬁed 20-mL syringe.
This device allows the subject to exhale the air
contained in the lower respiratory tract and to
trap the alveolar air that is needed for the
CO2 analysis. Air samples were also collected
at 30, 60, 90, and 120 min postcaffeine
administration. Duplicate samples were taken
at each time. Air samples (16 mL) were trans-
ferred into evacuated glass containers for
transport and storage to the laboratory. After
cryogenic puriﬁcation of the CO2 present in
exhaled air samples, the 13CO2:12CO2 ratio
was determined by differential gas-isotope
ratio mass spectrometry according to
Schoeller and Klein (1979). The quantity of
labeled CO2 exhaled was expressed as percent
labeled dose exhaled per hour (Schneider
et al. 1978). The excess 13CO2-exhaled/mmol
12CO2 for the dose was determined and mul-
tiplied by the basal CO2 production rate
(assuming 300 mmol/m2 of body surface per
hour) (Schneider et al. 1978; Schoeller and
Klein 1979). Results were expressed as the
2-hr cumulative exhalation of labeled CO2,
because it is the best monitor of caffeine clear-
ance in the adult (Kotake et al. 1982).
Urine analyses. Porphyrins (hepta-, hexa-,
pentacarboxylic porphyrins; uroporphyrins;
and coproporphyrins) in urine samples were
measured by high-performance liquid chro-
matography with a fluorescence spectro-
photometer (Johnson et al. 1988). The
detection limit is 0.5 pmol (25 nmol/L). The
within-run coefficients of variation for
25 nmol/L and 300 nmol/L were 4–12% and
3–5%, respectively.
D-Glucaric acid was measured by high-
performance liquid chromatography with an
ultraviolet detector after pretreatment of urine
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Figure 1. The Lower North Shore region of the St. Lawrence River (Québec, Canada).with boronic acid gel to remove interfering
substances such as L-ascorbic acid and 
D-glucuronic acid (Poon et al. 1993). The
detection limit of this method is 10 µmol/L
D-glucaric acid, and the run-to-run precisions
were 9.1 and 7.7% at concentrations of 60 and
310 µmol/L, respectively.
Smoking has been shown to induce
CYP1A2 activity in humans. Kotake et al.
(1982) reported that the 2-hr cumulative ex-
halation of 13CO2 for smokers was almost
2-fold the value for nonsmoking controls. We
measured cotinine concentration in urine sam-
ples by an ELISA method (COTI-TRAQ,
Serex Inc., NJ, USA). Creatinine concentra-
tion was determined by a modiﬁed Jaffe reac-
tion, using an automated colorimetric analyzer.
Plasma OC analyses. Concentrations of
ten chlorinated pesticides or metabolites
(aldrin, dieldrin, cis-chlordane, trans-chlordane,
p,p´-DDE, HCB, mirex, cis-nonachlor, trans-
nonachlor, oxychlordane) and 13 PCB con-
geners (IUPAC nos. 28, 52, 99, 101, 118, 128,
138, 153, 156, 170, 180, 183, 187) were
determined by HRGC/ECD. Plasma samples
were mixed with an aqueous solution of
ammonium sulfate and ethanol (1:1) and then
extracted with hexane. Extracts were concen-
trated and cleaned by elution through two
columns containing activated Florisil. We
performed the analysis by dual-column gas
chromatography, using an HP 5890 gas chro-
matograph equipped with two capillary
columns (HP Ultra 1 and Ultra 2, both 50 m
long, 0.2-mm inner diameter, 0.33-µm film
thickness) and twin electron capture detectors
(Hewlett Packard, Palo Alto, CA, USA). We
achieved identification and quantification of
the speciﬁc congeners by comparing responses
and retention times with calibration standards
for each analyte of interest. Recovery of OCs
varied between 90 and 103%. The detection
limit of the method was 0.05 µg/L for all com-
pounds. The within-run coefﬁcients of variation
for PCB congeners and chlorinated pesticides
ranged from 5.1 to 13.5% (at 0.4 µg/L).
OC concentrations were expressed on a
plasma lipid basis because blood samples were
not collected after a fasting period, which may
affect plasma OC concentrations (Phillips et al.
1989). To adjust OC concentrations on a lipid
basis, we used standard enzymatic procedures
to determine total and free cholesterol and
triglycerides. We measured phospholipids con-
taining choline by the enzymatic method of
Takayama et al. (1977), using a commercial kit
(Wako Pure Chemicals Industries, Richmond,
VA, USA). We estimated total plasma lipids
(TL) by adding the concentrations of choles-
terol esters [obtained by subtracting free
cholesterol from total cholesterol (TC)], free
cholesterol (FC), triglycerides (TG), and phos-
pholipids (PL), according to the following for-
mula (Phillips et al. 1989):
[1]
Quantiﬁcation of 2,3,7,8-chloro-substituted
PCDD/PCDF congeners and coplanar non-
ortho PCB congeners (IUPAC nos. 77, 126,
and 169) in plasma samples was performed by
AXYS Analytical Services Ltd. (Sydney, BC,
Canada). A 5–10 g plasma sample was spiked
with labeled surrogate standards (13C-labeled
analogs of the target PCDDs, PCDFs, and
coplanar PCBs) and extracted with an ethanol,
hexane, and saturated ammonium sulfate
mixture (1:1:1), and the hexane extract was
washed with concentrated sulfuric acid and
distilled water. The extract was then dried over
anhydrous sodium sulfate and cleaned up
using the following column chromatography
procedures: a) layered acidic-basic silica gel
column, eluted with hexane; b) activated alu-
mina column, eluted with hexane (discarded)
followed by elution with 1:1 dichloromethane:
hexane (collected); c) carbon on celite column
(4.75% carbon), eluted with hexane (dis-
carded), followed by 1:1 dichloromethane:
cyclohexane and then 10:1 ethyl acetate:toluene
(collected together for coplanar PCB congener
analysis), followed by inversion of the column
and elution with toluene (for collection of
PCDDs and PCDFs); d) activated alumina
column, each fraction (coplanar PCB and
PCDD/PCDF) applied to a new alumina col-
umn and eluted with hexane (discarded) and
1:1 dichloromethane:hexane (collected for gas
chromatograph/mass spectrometry analysis).
In preparation for gas chromatograph/mass
spectrometry analysis, an aliquot of 13C-labeled
recovery standard was added to each fraction
collected. Each fraction was analyzed by
HRGC/high-resolution mass spectrometry
(HRMS) using a VG Autospec Ultima high-
resolution mass spectrometer equipped with
an HP5890 gas chromatograph (Hewlett
Packard, Palo Alto, CA, USA). The chromato-
graphic separation was carried out using an
Agilent/J&W DB-5 capillary column (60 m
long, 0.25 mm inner diameter, 0.1 µm film
thickness; Agilent Technologies Canada Inc.,
Mississauga, ON, Canada).
DR-CALUX assay. Plasma samples (2 mL)
were mixed with an aqueous solution of
ammonium sulfate and ethanol (1:1) and then
extracted with hexane. Extracts were concen-
trated and cleaned by elution through two
columns containing activated Florisil. The
cleaned extracts were dissolved in dimethyl
sulfoxide (DMSO) for CALUX measurements
in 96-well plates using H4IIE.Luc cells (kindly
donated by A. Brouwer, Vrije Universiteit,
Amsterdam, the Netherlands). Cells were
grown in Dulbecco’s modiﬁed Eagle medium
with 10% fetal calf serum (Wisent Inc.,
St. Bruno, QC, Canada) in 96-well cell cul-
ture plates (Sarstedt Inc., Montreal, QC,
Canada) to 60–80% conﬂuence and exposed
during 24 hr in triplicate to the plasma
extracts, TCDD standards (AccuStandard,
New Haven, CT, USA), or DMSO alone
(vehicle; final concentration, 0.5% vol/vol).
Cells were then washed with PBS, lysed in
50 µL lysis buffer (Passive Lysis 5× buffer;
Promega, Madison, WI, USA) for 30 min,
and the lysate was frozen at 80°C. For meas-
urement of luciferase activity, samples were
thawed, and 20 µL lysate was pipetted into a
96-well microtiter plate (Dynex Technologies
Ltd., Worthing, UK). The plate was placed in
a Lmax luminometer (Molecular Devices
Corporation, Sunnyvale, CA, USA), and the
following sequence of events was programmed
for each well: a) injection of 100 µL luciferin
assay mix (Promega); b) 4-sec delay; c) light
production measured over a 10-sec period.
The limit of detection was approximately 5 pg
TEQ/g lipid for a 2-mL plasma sample
containing 7 g lipids/L.
Statistical analysis. Distributions of values
for OC concentrations as well as urinary glu-
caric acid and porphyrins concentrations were
skewed. Hence, we included the median in
descriptive statistics. We limited statistical
analyses to contaminants that were detected in
> 50% of the samples. For contaminants and
urinary measurements, a concentration equal
to half the detection limit was assumed for
samples with concentrations below the detec-
tion limit. Relations between biomarkers and
contaminants were assessed using Spearman’s
correlation coefficients. We used the Mann-
Whitney U-test to compare biomarker values
between age groups (≤ 45, > 45 years), smok-
ing categories (smokers, nonsmokers), and
alcohol consumption categories (occasional
drinkers, abstainers). Nonparametric analyses
were selected because of the skewed distribu-
tions and the small sample sizes. The level of
statistical signiﬁcance was set at 0.05. We used
the SPSS for Windows statistical software
package (version 11.5; SPSS Inc., Chicago, IL,
USA) to perform all statistical analyses.
Results
Characteristics of participants. Forty volun-
teers (23 women, 17 men) were recruited in
the two Lower North Shore communities.
The mean age of the participants was 47 years
(range, 25–75 years). Ten subjects were on
continuous medication at the time of the
study, including two taking anticonvulsants
(phenobarbital and phenytoin). The group
consisted of 17 smokers and 23 nonsmokers,
as determined by self-declared cigarette con-
sumption and urinary cotinine results (urine
cotinine concentration > 0.8 µg/mL).
Fourteen participants drank alcohol occasion-
ally, whereas 26 were abstainers. Mean body
mass index was 27.0 (SD = 4.0).
Biomarkers of exposure. Plasma concentra-
tions of the various OCs that were detected in
TL TC FC FC TG PL =+ + + 1 677 .(–) .
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Major PCB congeners were congeners 153,
180, and 138. These three congeners repre-
sented 68% of the total PCB concentration in
plasma lipids. Simple correlation analysis
revealed strong associations (Spearman’s
r > 0.78; p < 0.001) between PCB-153 concen-
trations and those of congeners 99, 138, 156,
170, 180, 183, and 187. Correlations between
PCB-153 concentrations and those of mono-
ortho PCBs 105 and 118 were somewhat lower
(Spearman’s r = 0.52 and 0.58, respectively;
p < 0.001). Among chlorinated pesticides, p,p´-
DDE was the most abundant compound in
plasma, followed by HCB, trans-nonachlor,
oxychlordane, and mirex, which showed much
lower concentrations (> 10-fold).
DLC concentrations determined by the
DR-CALUX assay were moderately correlated
with total PCB concentrations (Spearman’s
r = 0.45; p = 0.003). Similar correlations were
noted between DLC concentrations and either
PCB-153 concentrations or total concentra-
tions of mono-ortho congeners (105, 118, and
156) expressed in nanogram TEQs per kilo-
gram plasma lipids. In a subset of participants
(n = 15), concentrations of PCDDs/
PCDFs and non-ortho coplanar PCBs were
measured by HRGC/HRMS and expressed as
total TEQ concentrations using the World
Health Organization’s toxic equivalency factors
(Van den Berg et al. 1998). The latter was sig-
niﬁcantly correlated with the TEQ concentra-
tion measured by the DR-CALUX assay in the
same samples (r = 0.66; p = 0.008; Figure 2).
Biomarkers of hepatic enzyme induction.
Results for hepatic enzyme induction biomark-
ers are presented in Table 2. D-Glucaric acid
was detected in urine samples from 95% of
participants (38 of 40). The coefficient of
variation (CV) exceeded 100% for this para-
meter, indicating that the distribution was
highly skewed. Two participants, one being
treated with phenobarbital and another with
phenytoin, exhibited the two highest concen-
trations (26.0 and 14.9 mmol/mol creatinine,
respectively). Eliminating these two values
reduced the mean from 4.4 to 3.6 mmol/mol
creatinine and the CV to 61%.
Coproporphyrins were present in all urine
samples, whereas uroporphyrins were above
the limit of detection in only 15% of samples
(6 of 40). Penta-, hexa-, and heptaporphyrins
were not detected in any urine sample. The
distribution of coproporphyrin concentrations
was slightly skewed. The highest value was
observed for the individual taking phenobarbi-
tal. Eliminating the two subjects on anticon-
vulsant medication slightly reduced the mean
(from 11.5 to 11.1 µmol/mol creatinine) and
the CV (from 30 to 28%).
The CBT was successfully administered
to 21 participants. This parameter followed a
normal distribution with the mean very close
to the median value and a CV of 41%. Only
one subject that underwent the CBT was on
antiepileptic medication, and eliminating this
subject did not substantially modify the statis-
tical descriptors of the distribution.
We examined relations between biomark-
ers of effects and found that urinary D-glucaric
acid concentrations were weakly correlated
with urinary coproporphyrin concentrations
(Spearman’s r = 0.36; p = 0.02), whereas the
latter were moderately correlated with the CBT
(r = 0.57; p = 0.006). D-Glucaric acid concen-
trations were not correlated with CBT results.
Biomarkers of exposure versus biomarkers
of hepatic enzyme induction. We explored the
relationship between biomarkers of exposure
and biomarkers of hepatic enzyme induction.
To this end, we used correlation analyses after
excluding results from the two individuals tak-
ing anticonvulsants, in view of the known
enzyme-inducing effects of these agents
(phenobarbital and phenytoin). Urinary coti-
nine concentration was positively related to the
CBT (Table 3). We selected PCB-153 to rep-
resent the group of persistent PCB congeners
in those analyses and did not observe statisti-
cally signiﬁcant correlations with any biomark-
ers of effects. DLC concentrations as measured
by the DR-CALUX were also not correlated
with biomarkers of effects. Age, gender, and
alcohol consumption were not associated with
the biomarkers of effects (data not shown).
Next, we tested correlations between effects
biomarkers and concentrations of mono-ortho
PCB congeners 105 and 118, which did not
exhibit strong collinearity with PCB-153. We
found moderate inverse correlations between
these mono-ortho congeners and the results
from the CBT, which reached statistical signiﬁ-
cance for PCB-105 (p = 0.05). We hypothe-
sized that the latter results may indicate
increased biotransformation of PCB-105 and
PCB-118 in participants with increased liver
CYP1A2 activity. We further tested correlations
between CYP1A2 activity and PCB-105:
PCB-153 and PCB-118:PCB-153 concentra-
tion ratios to take into account the difference in
PCB exposure between participants, which is
best represented by concentrations of PCB-153
(a very persistent congener). We observed
stronger negative correlations between CYP1A2
activity and these congener ratios than those
noted above (Figure 3), further suggesting that
PCB-105 and PCB-118 are biotransformed at
an increased rate in participants exhibiting high
CYP1A2 activities. Similar correlation coefﬁ-
cients were observed after stratifying for age
(≤ 45, > 45 years) and gender (data not shown).
Biomarkers in a fish-eating population
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Table 1. Plasma OC concentrations in 40 residents of fish-eating communities along the Lower North
Shore of the St. Lawrence River (Québec, Canada).
OC Median Arithmetic mean SD Minimum Maximum
PCBs
PCB-99 127 137 80 12 308
PCB-105 32 37 25 < 7a 107
PCB-118 145 167 103 32 437
PCB-138 533 553 274 36 1,164
PCB-153 766 817 398 90 1,668
PCB-156 87 91 51 15 218
PCB-170 151 167 91 24 359
PCB-180 629 645 361 85 1,447
PCB-183 64 70 35 < 7a 136
PCB-187 177 194 94 17 378
Total PCBsc 2,820 2,897 1,372 334 5,880
Chlorinated pesticides
p,p´-DDE 1,086 1,681 1,576 56 6,262
HCB 104 101 42 35 223
Oxychlordane 43 53 48 < 7b 182
Mirex 46 47 32 < 7b 115
trans-Nonachlor 87 98 47 16 223
DLCsc 93 102 57 37 287
PCBs and chlorinated pesticides were analyzed by HRGC/ECD and are reported in units of microgram per kilogram lipids. 
aThe limit of detection is 0.5 µg/L, which corresponds to approximately 7 µg/kg lipids. bSum of 13 congeners. cDLCs were
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Figure 2. Correlation between concentrations of
DLCs in plasma lipids determined by the DR-CALUX
bioassay and those determined by HRGC/HRMS.
r = 0.66; p = 0.008Biomarkers of effects and smoking status.
Results for biomarkers of effects were stratiﬁed
according to the smoking status because of the
known effect of smoking on liver enzyme activ-
ities (Table 4). There was a tendency toward
higher CBT values in smokers than in non-
smokers, with the median value of smokers
being 70% higher than that of nonsmokers
(p = 0.07). The other biomarkers were not inﬂu-
enced by the smoking status of the participants.
Discussion
We measured biomarkers of effects, more
specifically, markers of hepatic microsomal
enzyme induction, in residents of a remote
coastal region of Québec who rely partly on
sea products for sustenance. Our hypothesis
was that biomarkers of hepatic enzyme induc-
tion would be increased as a result of the
chronic exposure to OCs in this fish-eating
population. Participants displayed high
concentrations of several persistent, lipophilic
compounds that are biomagniﬁed in aquatic
food chains such as PCBs, chlorinated pesti-
cides, and DLCs. However, despite this high
exposure, we did not ﬁnd any statistically sig-
niﬁcant relations between biomarkers of OC
exposure and markers of hepatic enzyme
induction in this population.
Urinary D-glucaric has been suggested as a
biomarker of effect induced by PCB exposure.
Apostoli et al. (2003) reported a median con-
centration of 5.5 mmol/mol creatinine, with
values ranging from 1.7 to 12.4 mmol/mol
creatinine in 73 subjects who were exposed to
PCBs through eating farm produces contami-
nated by runoff water from a nearby dielectric
fluid plant. Somewhat lower values were
obtained in our group: the median was
3.4 mmol/mol creatinine and the range spread
from < 0.8 to 9.8 mmol/mol creatinine, when
we excluded the two highest values displayed
by subjects taking enzyme-inducing anti-
convulsants. In results similar to ours, Apostoli
et al. (2003) did not observe any relation
between plasma PCB levels and urinary
D-glucaric acid concentrations; smoking was
also not related to this biomarker of enzyme
induction. Median total PCB plasma concen-
tration in their participants was 27 µg/L
(range, 1.1–394 µg/L), compared with
18 µg/L (range, 2.5–61 µg/L) in our group. In
workers with higher PCB exposure (total PCB
plasma concentrations ranging from 88 to
1,359 µg/L), Maroni et al. (1984) noted a
higher D-glucaric concentration than in an
unexposed comparison group. However, the
correlation of PCB plasma concentrations
with D-glucaric concentrations was not statisti-
cally significant. Children and adults from
Seveso, Italy, who were highly exposed to
TCDD after its release to the atmosphere
because of a malfunction in a chemical plant
showed a statistically significant increase of
D-glucaric acid elimination compared to the
control groups, even 3 years after the accident
(Ideo et al. 1985). Hence, although D-glucaric
acid concentrations are elevated in urine
samples of individuals who have been highly
exposed to dioxins, it does not appear to be
sensitive enough in situations involving low-
level environmental PCB exposure.
With regard to urinary porphyrins, copro-
porphyrins were detected in all participants,
whereas the other porphyrins were rarely if
ever present in concentrations exceeding the
detection limit of the analytical method
(25 nmol/L). Furthermore, we did not
observe any correlation between OCs and uri-
nary coproporphyrin levels. Provided a sufﬁ-
cient exposure dose, several halogenated
aromatic hydrocarbons can lead to increased
urinary porphyrin excretion (Hogue and
Brewster 1991). However, although acute
poisoning and high occupational exposure to
Ayotte et al.
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Table 2. Biomarkers of effects in 40 residents of ﬁsh-eating communities along the Lower North Shore of
the St. Lawrence River (Québec, Canada).
No. Arithmetic
Biomarkers detected Median mean SD Minimum Maximum
D-Glucaric acid (mmol/mol creatinine) 38 3.4 4.4 4.5 < 0.8 26.0
Uroporphyrins (µmol/mol creatinine) 6 1.2 1.2 0.4 < 0.4 2.2
Coproporphyrins (µmol/mol creatinine) 40 11.0 11.5 3.5 5.7 19.2
CBT (% total)a 21b 5.3 5.4 2.2 1.9 9.6
aPercentage of total 13C dose exhaled as 13CO2 over a 2-hr period. bThe CBT was administered to the 40 participants, but
for 19 of them CO2 concentrations in air samples were too low for isotopic analysis to be performed.
Table 3. Correlationsa between biomarkers of exposure and biomarkers of effects in residents of ﬁsh-eat-
ing communities along the Lower North Shore of the St. Lawrence River (Québec, Canada).
Biomarker Urinary D-glucaric acid (n = 38) Urinary coproporphyrins (n = 38) CBT (n = 20)
exposure/effects rp -Value rp -Value rp -Value
Cotinine 0.28 0.09 0.10 0.57 0.60 0.005
PCB-153 0.20 0.22 0.06 0.73 0.07 0.76
PCB-105 –0.05 0.75 –0.24 0.15 –0.45 0.05
PCB-118 0.01 0.99 –0.22 0.18 –0.41 0.07
DLCs 0.23 0.18 0.01 0.98 0.12 0.61
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Figure 3. Inverse correlations between liver CYP1A2 activity (CBT values) and plasma concentrations of
(A) PCB-105 (r = –0.62; p = 0.003) and (B) PCB-118 (r = –0.53; p = 0.02) in 20 residents of the Lower North
Shore of the St. Lawrence River.
Table 4. Biomarkers of effects in relation to the smoking status in residents of fish-eating communities
along the Lower North Shore of the St. Lawrence River (Québec, Canada).
Nonsmokers Smokers
Biomarker Median Mean SD n Median Mean SD np -Valuea
D-Glucaric acid (mmol/mol creatinine) 3.6 3.6 1.7 21 2.9 3.6 2.6 17 0.33
Coproporphyrins (µmol/mol creatinine) 9.8 10.7 3.3 21 11.3 11.7 2.9 17 0.28
CBTb 3.6 4.7 2.3 13 6.1 6.7 1.8 7 0.07
ap-Value for Mann-Whitney U-test. Comparisons were effected after excluding two individuals taking anticonvulsants.
bResults of the CBT are expressed as the percent of total 13C dose exhaled as 13CO2 over a 2-hr period.these compounds are clearly porphyrogenic
(Daniell et al. 1997), environmental exposure
has not been linked to porphyrinuria. A
recent study conducted among 241 residents
of Flix (Catalonia, Spain), a village located
near an electrochemical factory where high
atmospheric levels of HCB were detected,
revealed lower urinary levels of copropor-
phyrins in participants exhibiting the highest
HCB plasma levels (Sunyer et al. 2002). With
regard to DLCs, Calvert et al. (1994) did not
ﬁnd an increased risk of showing out-of-range
urinary uroporphyrin or coproporphyrin con-
centrations in U.S. workers exposed to
TCDD, compared to referents. Moreover, a
subgroup of 10 workers who had a mean
serum TCDD concentration of 559 pg/g
lipids (range, 769–1,593 pg/g lipids) at the
time of the study had similar coproporphyrin
levels as those of the referents (Calvert et al.
1994). Considering the lower exposure to
DLCs documented in our ﬁsh-eating popula-
tion (range, 37–287 pg TEQs/g lipids), the
observed lack of porphyrogenic effect in rela-
tion to DLC exposure is consistent with
evidence in the literature.
During the last 15 years, the CBT has
been used to assess in vivo liver CYP1A2 activ-
ity in various population subgroups. Hepatic
microsomal caffeine N-3-demethylation, the
initial major step in caffeine biotransformation
in humans, is selectively catalyzed by CYP1A2
(Butler et al. 1989). Among subjects without
any known exposure to pharmaceutical or
environmental enzyme inducers, CYP1A2
activity in smokers is 1.5–2 times that of non-
smokers (Abraham et al. 2002; Kotake et al.
1982; Lambert et al. 1986). A group of
51 Michigan farmers, who were exposed to
polybrominated biphenyls when a ﬂame retar-
dant was accidentally added to dairy cattle
feed, showed a greater median CYP1A2 activ-
ity that that of unexposed Illinois residents
(Lambert et al. 1990). The authors also
reported a weak positive correlation between
serum polybrominated biphenyl concentra-
tions and CBT values, although close inspec-
tion of the data indicates that this correlation
is mainly due to five individuals with high
plasma concentrations (> 300 µg/L). The
median CBT value for Taiwanese who were
accidentally exposed to PCB/PCDF through
the ingestion of contaminated rice oil
(Yu-Cheng patients) was 440% higher than
that of the unexposed control group (Lambert
et al. 1992). In contrast, subjects exposed to
TCDD after the Seveso incident did not
exhibit high CBT values when tested
16–18 years after their exposure (Brambilla
et al. 1995). Initially, concentrations of
TCDD up to 6,300 ppt had been measured in
plasma samples from these individuals, but
contemporary levels were not mentioned by
the authors. Abraham et al. (2002) also used
the CBT to measure CYP1A2 activity in two
women highly exposed to TCDD, one man
moderately exposed, and 50 control subjects
(30 nonsmokers and 20 smokers). Results
indicated that in the women with very high
TCDD exposure (> 10,000 ppt), CYP1A2
activity (as measured by the CBT) was at least
5 times the mean activity observed in non-
smoking controls. The individual moderately
exposed (1,000 ppt) exhibited a CYP1A2
activity similar to that of smokers in the con-
trol group, and at the high end of values dis-
played by nonsmoking controls (Abraham
et al. 2002). With total DLC concentrations
not exceeding 300 ppt in our participants, we
conclude that their exposure level was too low
to induce liver CYP1A2 activity above base-
line, as measured by the CBT.
We observed a moderate correlation
between liver CYP1A2 activities (CBT values)
and urinary coproporphyrin concentrations in
our participants. In the study by Sunyer et al.
(2002) discussed above, smokers had a higher
concentration of coproporphyrin III, which
was the major coproporphyrin in urine sam-
ples. The authors mentioned that this ﬁnding
agreed with a possible indirect effect of ciga-
rette smoking through CYP1A2 induction.
CYP1A2 has been involved in disturbances of
porphyrin metabolism in mice but not in
humans (Gorman et al. 2002; Sinclair et al.
2000). Our findings do support a possible
link between altered porphyrin metabolism
and liver CYP1A2 activity in humans.
A major strength of our study is the use of
a cell-based assay, the DR-CALUX assay, to
measure the total concentration of DLCs in
plasma samples of participants. A moderate
correlation was observed between results from
this bioassay and the analytical chemistry
method, indicating that the DR-CALUX
assay is indeed responding to AhR agonists
extracted from plasma samples. We did not
expect a strong correlation with the analytical
chemistry data because the bioassay integrates
the contributions from all AhR agonists
extracted from plasma, including several that
are not measured by the HRGC/HRMS
method that is, xenobiotics such as polycyclic
aromatic hydrocarbons (Seidel et al. 2002),
dietary components such as flavonoids
(Amakura et al. 2003), or endogenous com-
pounds such as bilirubin and biliverdin
(Phelan et al. 1998). In addition, mixtures of
DLCs extracted from the plasma may not
induce responses that are additive in the
DR-CALUX, unlike the assumption made by
summing the contributions of all DLCs meas-
ured by analytical chemistry to yield a total
TEQ concentration (Safe 1990).
Because of the small number of participants
in this study, one could question its power to
detect associations between effect biomarkers
and exposure variables. With 20 subjects,
power was sufﬁcient to detect the fairly strong
positive association between smoking and liver
CYP1A2 activity (urinary cotinine concentra-
tions vs. CBT values, r = 0.60; p = 0.005). In
contrast, correlation coefﬁcients between bio-
markers of hepatic enzyme induction and bio-
markers of exposure (DLCs and PCB-153)
ranged from 0.07 to 0.23, indicating weak
associations between these variables at best.
Although we cannot rule out an effect of OC
exposure on hepatic enzyme activity, our
results suggest that, in this population, OC
exposure is less important than smoking as an
inducing factor of CYP1A2 activity. Similar
results were obtained by Pereg et al. (2002),
who measured CYP1A1 activity in placenta
samples obtained from Inuit women giving
birth in Nunavik (northern Québec, Canada).
These authors noted a statistically signiﬁcant
relationship between placental CYP1A1 activ-
ity and smoking but not with OC body bur-
den, hence suggesting, as in the present study,
that environmental OC exposure was not high
enough in this population to induce AhR-
mediated effects.
The inverse correlation noted in the pres-
ent study between liver CYP1A2 activity and
plasma concentrations of PCB-105 and
PCB-118 is of interest for two reasons. First, it
supports a role for CYP1A2 in mediating the
biotransformation of these mono-ortho con-
geners in humans. Brown et al. (1989) previ-
ously reported a particular profile of PCB
congeners in plasma samples of PCDF-
exposed individuals that featured relatively low
concentrations of these mono-ortho congeners
compared with concentrations of di-ortho con-
geners. Second, the negative relation of
CYP1A2 to mono-ortho PCBs emphasizes the
importance of considering other factors linked
to CYP1A enzyme activities as possible causal
agents whenever an association between
plasma concentrations of these mono-ortho
congeners and disease is observed in epidemio-
logic studies. Indeed, we expect plasma con-
centrations of these congeners in an individual
to be inﬂuenced by dietary, environmental, or
lifestyle exposures to compounds that either
induce (i.e., polycyclic aromatic hydrocarbons
in cigarette smoke) or inhibit CYP1A enzymes,
or by functional genetic polymorphisms for
these enzymes. Hence, the plasma concentra-
tion of mono-ortho PCBs might be a surrogate
of CYP1A enzyme activity in the individual,
the latter being directly or indirectly linked to
the disease. In a recent case–control study in
which we noted an association between breast
cancer risk and plasma concentrations of
mono-ortho PCBs (Demers et al. 2002), we
speculated that the association could be
explained by CYP1A enzyme activities in
women altering both plasma concentrations
of mono-ortho PCBs and estradiol levels, the
latter being the causal agent.
Biomarkers in a fish-eating population
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In summary, we found no relation between
biomarkers of OC exposure and markers of
hepatic enzyme induction in this highly
exposed group of fish eaters from the Lower
North Shore of the St. Lawrence River. Our
results suggest that smoking induces liver
CYP1A2 activity, which in turn alters por-
phyrin metabolism and increases the biotrans-
formation of mono-ortho PCBs.
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